TOP STORIES

• REGULATORY MHLW Bureaucrats Think Chuikyo Will Spurn Annual Drug Price Revisions, Again
  April 28, 2014

• REGULATORY Chuikyo Subcommittee OKs Point-Based Premium Calculation Method, Adoption Scheduled in May
  April 24, 2014

• BUSINESS MTPC Names Masayuki Mitsuka as New President
  April 24, 2014

• BUSINESS Astellas Aims to Dominate SGLT-2 Inhibitor Market with Suglat
  April 23, 2014

• BUSINESS Lilly Japan Starts PIII Study of Tadalafil for DMD Treatment
  April 22, 2014

• REGULATORY MHLW Eyes 2 Year Transition for Electronic Data Submissions for New Drugs, Biosimilars
  April 21, 2014

• REGULATORY New Health Ministry Panel to Compile Report on Clinical Research Regulations by Autumn
  April 18, 2014

• REGULATORY Blue Letter on Xeplion Issued Following 21 Reported Deaths; Causal Relationship Remains Unclear
  April 18, 2014

• BUSINESS Sanofi Aims to Top SGLT-2 Inhibitor Market with Apleway
  April 18, 2014

• REGULATORY Govt Panel Members Pitch Yearly NHI Price Cut, 0.8 Trillion Yen Could’ve Been Pruned over 7 Years
  April 17, 2014

• BUSINESS Metal Found in Voltaren Product Again: Novartis
  April 17, 2014

• ORGANIZATION Funding for Investigator-Led Studies Should Be Based on Contracts: EFPIA Japan
  April 16, 2014

• BUSINESS FY2015 Recruitment Plan: Eisai to Resume Offering Jobs to New Graduates
  April 15, 2014

• BUSINESS Novartis Pharma Notified Police about Metal Object Found in Voltaren Product
  April 15, 2014

• ACADEMIA Public Hospitals Seeking to Avert Penalty Fee Cuts for Low Price Settlements
  April 14, 2014

• BUSINESS 10% of Valsartan Franchise Prescriptions Switched to Other ARBs, Azilva, Micamlo Top Lists
  April 11, 2014

• REGULATORY Chuikyo OKs Listing of 14 APIs including Japan’s First SGLT-2 Inhibitor
  April 10, 2014

• BUSINESS Livalo Lawsuit: Does Use of “PITAVA” by Generic Makers Infringe Kowa Trademark?
  April 9, 2014

• BUSINESS Sun Deal Not Meant to Sever Ties with Ranbaxy: Daiichi Sankyo Pres.
  April 8, 2014

• BUSINESS India’s Sun Pharma to Acquire Ranbaxy via Equity Swap Deal, Taking Ranbaxy Off Daiichi Sankyo Scorecard
  April 7, 2014

ページ

• « 先頭
• ‹ Prev
• …
• 204
• 205
• 206
• 207
• 208
• 209
• 210
• 211
• 212
• …
• Next ›
• 最終 »